Before the drug · which of the three deficits you actually have
INGESTIBLE // MOLECULAR
◇ WHAT IT IS
Nobody reaches for a wakefulness drug because they are curious. They reach for it because something is wrong, and the drug is the fastest thing on the shelf. This protocol exists because that something is almost always one of three states — and the drug treats all three identically, which is exactly why it disappoints.
Sleep debt is a quantity problem: not enough hours, accumulating. Circadian displacement is a timing problem: the hours exist but they are in the wrong place, and the body is being asked to perform out of phase. Load exceeding recovery is a capacity problem: the hours and the timing are fine, and the demand has simply outrun what is being absorbed. They feel identical from the inside. They are not the same thing, and only one of them is solved by staying awake harder.
The audit is not sophisticated and does not need to be. Seven days of honest measurement separates the three, and the separation tells you which of the interventions in this compendium is the one that applies to you. What it will not do is tell you to take anything — the source dossier grades that question at certainty 37, and a protocol cannot be more confident than the evidence beneath it.
One thing worth saying plainly, because it is the whole reason this page exists rather than a dosing schedule: a wakefulness drug does not settle a sleep debt. It lets you keep paying interest on it. The debt continues compounding underneath, and the compounding is invisible precisely because the symptom has been removed.
◇ THE COMPONENTS
Seven nights of sleep durationQuantity. Not how you felt — hours actually logged, from a wearable or a written log. Perception of sleep length is unreliable in exactly the people who need this audit.
Bed and wake times, weekday against weekendTiming. The gap between your weekday and weekend midpoint is the cleanest available read on circadian displacement, and most people have never calculated theirs.
Resting heart rate and HRV trendCapacity. Direction over a week matters; a single night says almost nothing. This is the layer that separates load from the other two.
A training and workload logThe denominator. Recovery can only be judged against what is being recovered from, and most people underestimate cognitive load as a physiological demand.
Caffeine timing — not quantityThe most common confound in this audit. Late caffeine produces a circadian signature that mimics displacement, and it is free to test by moving it earlier for a week.
◇ HOW TO DEPLOY — DAILY TIMING
DAYS 1–7Log sleep duration nightly without changing anything. Changing behaviour during the measurement week destroys the baseline you are trying to establishMeasurement
DAY 7 · TEST ONEAverage under roughly 7 hours? That is SLEEP DEBT — a quantity problem. Stop here. No timing or load intervention outperforms returning the hours, and none of them work while the debt standsDifferential
DAY 7 · TEST TWOHours adequate, but weekday and weekend midpoints differ by more than about an hour? That is CIRCADIAN DISPLACEMENT — a timing problem. The lever is light and temperature, not willpower and not a stimulantDifferential
DAY 7 · TEST THREEHours adequate, timing stable, and resting HR drifting up while HRV drifts down? That is LOAD EXCEEDING RECOVERY. The intervention is subtraction, and adding a drug here makes the ratio worse rather than betterDifferential
IF NONE OF THE THREEPersistent unexplained daytime sleepiness with adequate, well-timed sleep and no load excess is a clinical question, not an optimisation one. Sleep apnoea and narcolepsy are diagnoses, and this is where this protocol ends and a physician beginsClinical
BEFORE ANY DRUG CONVERSATIONBring the seven days with you. A physician can do something with a measured differential that they cannot do with 'I am tired all the time' — and the audit is worth running even if the conversation still ends in a prescriptionJudgement
◇ WHAT CHANGES IN YOUR DAY
You stop treating three different problems with one answer. The reason a wakefulness drug underdelivers for most people is that most people do not have the deficit it corrects — and nobody checked first.
You get a differential a clinician can use. Seven days of logged duration, timing and trend changes the quality of the consultation more than any symptom description can.
You find out whether the intervention is free. Two of the three states are addressed with light, timing and subtraction — no prescription, no supply chain, no risk profile.
2035 HORIZONPROJECTION · NOT PROVEN FACT
The audit stops being manual
Every input here — duration, timing midpoint, HRV and resting-HR direction, load — is already produced by a wearable and already separated by the OCCABUZZ advisory engine as distinct findings. This protocol is the hand-run version of something that becomes automatic the moment an operator connects their own telemetry. Projection, not a claim about a shipped feature.
Responder identification, if anyone funds it
A pooled SMD of 0.12 is an average, and an average can hide a minority who respond well. No published trial has identified who they are. If that work is ever done, the honest grade on the source dossier moves — and it moves in public, with the change logged. Until then, nobody can tell you in advance whether you are one of them, and any seller who implies otherwise is selling.
⧗ OPERATOR ADVISORY
Informational, not medical advice. This protocol contains no dosing guidance and deliberately does not tell you to take, or not take, any medication — those are clinical decisions made with a licensed physician. Modafinil is prescription-only; in the European Union its authorisation has been restricted to narcolepsy since 2011, and it carries a warning for serious, sometimes fatal skin reactions. Persistent daytime sleepiness can indicate conditions including sleep apnoea and narcolepsy, which require diagnosis rather than optimisation.
◇ THE STANDARD // APPLIED TO THIS ASSET
◇ THE AUDIT — THIS ASSET, ON THE STANDARDCALIBRATED CERTAINTY = ∛(E · C · I)
Applies to healthy apex, not only to clinical deficit.
03 IMPLEMENTATION28
Survives a demanding calendar. Zero executive friction.
EMERGING
Signal is real but unproven. Watchlist, not protocol.
The sliders start at the OCCABUZZ assessment for this asset. Drag any layer to test the standard against our call.
The score is a geometric mean — a single failed layer collapses it. Excellence in two cannot rescue a gap in the third. That is why hype scores low and proven, feasible, broadly-applicable work scores high. The restraint is the product.